CPIG
KDNY

Chicago Partners Investment Group’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Chicago Partners Investment Group’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-255
Closed -$6K – 980
2018
Q3 		$6K Hold
255
– – ﹤0.01% 898
2018
Q2 		$9K Hold
255
– – ﹤0.01% 827
2018
Q1 		$12K Hold
255
– – ﹤0.01% 746
2017
Q4 		$10K Hold
255
– – ﹤0.01% 754
2017
Q3 		$14K Sell
255
-255
-50% -$15.2K ﹤0.01% 725
2017
Q2 		$30K Buy
+510
New +$25.6K 0.01% 461

Other funds holding KDNY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Chicago Partners Investment Group's KDNY Position: Q4 2018 in Review

Chicago Partners Investment Group sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q4 2018, closing a stake of 255 shares — an estimated $6K sold.

Chicago Partners Investment Group first reported a position in KDNY in Q2 2017 and held it in 6 quarters. The position peaked at $30K in Q2 2017. 85 funds tracked by Wall St. Rank hold KDNY as of Q4 2018.

  • Chicago Partners Investment Group reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Chicago Partners Investment Group sold 255 Chinook Therapeutics, Inc. Common Stock shares in Q4 2018, an estimated $6K.
  • Chicago Partners Investment Group first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2017 and held it in 6 quarters.
  • Chicago Partners Investment Group's Chinook Therapeutics, Inc. Common Stock position peaked at $30K in Q2 2017.
  • 85 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q4 2018.

Based on Chicago Partners Investment Group's 13F filing for Q4 2018, filed 11 Jan 2019.